Biotechnology-Based Detection of Food Contaminants: Implications for Food Safety, Agricultural Trade, and Economic Loss Reduction

Abstract

Food contamination by microbial pathogens, mycotoxins, pesticide residues, heavy metals, and adulterants causes an estimated several hundred million episodes of foodborne illness annually, kills hundreds of thousands of people each year, and imposes economic losses on producers, processors, and trading nations that are measured in tens of billions of dollars. Detection is the hinge of every food-safety system: hazards that are found early and cheaply are managed, while hazards that are found late, or not at all, become public health events, trade rejections, and destroyed livelihoods. Conventional analytical methods (culture-based microbiology, chromatography, mass spectrometry) are accurate but slow, centralized, expensive, and poorly matched to the scale and geography of risk in modern supply chains. This review synthesizes the biotechnology-based detection platforms that have emerged over the past decade, polymerase chain reaction and isothermal nucleic-acid amplification, immunoassay and lateral-flow formats, aptamer-based and electrochemical biosensors, CRISPR-based nucleic-acid detection, and omics- and data-driven screening, and evaluates their performance, costs, and deployment requirements across contaminant classes. It then traces the consequences of detection capability (and its absence) through three connected domains: domestic food safety and public health; international agricultural trade, where sanitary and phytosanitary measures, import alerts, and rejections redistribute income between and within countries; and farm- and firm-level economic losses from recalls, destroyed stock, and lost market access. The synthesis shows that biotechnology-based detection shifts the economics of food safety from ex-post catastrophe management to ex-ante risk control, with the largest marginal returns in the testing gaps of developing-country production and export systems. Barriers, laboratory infrastructure, quality assurance, regulatory recognition, and cost at the point of sale, are analyzed, and a phased adoption pathway is proposed linking portable platforms, sentinel surveillance networks, and trade-facing accreditation.